Some patients choose to stop semaglutide after reaching their goal weight, but this should be done under medical supervision
Our study covers a broad group of patients and provides strong support that GLP-1 analogues are not associated with an increased risk of thyroid cancer, he added
According to these controversies about the effect of T replacement therapy on CV risk, the US Food and Drug Administration (FDA) added restrictions through a warning statement on this substitutive treatment
Musculoskeletal Recovery Patients on GLP-1 therapy often increase physical activity as part of their weight management program
Mol Gen Genomics 272:639650 Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-DeltaC(T)) method
Liu M, Zhu H, Zhu Y, Hu X